“…26 XGBoost, an advanced gradient-boosting framework, builds an ensemble of decision trees to enhance predictive accuracy. 27 Candidate variables were selected based on the previous literature, including primary tumor location, T and WORLD JOURNAL OF SURGERY -2761 N categories, KRAS status, DFI, CEA levels, administration of NAC, and TBS-all of which can be discerned in the preoperative period. 6,17,[28][29][30][31] To reduce overfitting, a 10-fold cross-validation was employed on the entire cohort.…”